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Introduction
Pharmaceuticals include more than 4000 mole-
cules with different physicochemical and biological 
properties and distinct modes of biochemical ac-
tion.1 They belong to the group of emerging con-
taminants in the environment and are the most rele-
vant substances for the possible impact on aquatic 
ecosystems due to their frequent use and physico-
chemical properties. With more advanced analytical 
methods, residues of pharmaceuticals are found in 
concentrations up to μg dm–3 in surface water2 in 
developed countries, and up to mg dm–3 in develop-
ing countries3. Release sources of pharmaceuticals 
in the environment are, for example, households, 
hospitals, livestock farms, pharmaceutical produc-
tion, wastewater treatment plants or improper dis-
posal of out-of-date medicines.4 Most of these 
 discharges have not been regulated yet, and the en-
vironmental fate of pharmaceuticals is not well un-
derstood.5,6 Therefore, there is a growing interest for 
the disposal of such residues that could have poten-
tial negative effects on ecosystems.7 Antibiotics, 
among all pharmaceuticals, are extensively used in 
treatment of diseases, and as such, their antimicro-
bial residues can have potentially adverse effects on 
humans.8 In the last decades, antibiotic compounds 
have been considered as ‘‘emerging contaminants’’ 
due to their relatively high consumption and pseu-
do-persistence in the environment.6,9
Conventional wastewater treatment approaches 
are usually ineffective at degrading pharmaceutical 
contaminants like antibiotics, because most such 
contaminants show poor solubility in water.4 There-
fore, different research groups have been focusing 
on other degradation processes, such as photochem-
ical transformations and photocatalytic decomposi-
tions in order to increase removal efficiency.10 Re-
cently, a lot of research has been focused on the 
area of microbial biodegradation or biotransforma-
tion of antibiotics11–13, because biological treatment 
is a preferred option in terms of economic costs and 
ecological footprint. The ability of microorganisms 
to metabolize complex chemicals and large amounts 
of organic compounds represent one of the most im-
portant processes.14,15 Most of the studies on biodeg-
radation of pharmaceuticals investigated the remov-
al of these compounds by mixed cultures of 
microorganisms.13,16 However, it is easier to isolate 
the effects and behavior of individual strains, which 
could facilitate process optimization. Many bacteria 
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have developed enzymatic pathways not only to de-
activate antibiotics (which usually involves one or 
bond cleavages, but not complete breakdown of the 
antibiotics), but also to metabolize the antibiotics 
(involving their complete breakdown/transforma-
tion).17,18
The aim of this research was to study the sus-
ceptibility of environmental microorganisms to the 
macrolide antibiotic erythromycin. The main inter-
est was to investigate the possibility of biodegrada-
tion by Pseudomonas aeruginosa 3011. This would 
contribute to the development of simpler and more 
efficient processes for the removal of pharmaceuti-
cals in the environment.
Materials and methods
Antimicrobial susceptibility test
Prior to the biodegradation experiments, the 
antimicrobial susceptibility tests19 on antibiotic 
erythromycin were performed with bacteria Pseu-
domonas aeruginosa 3011, Bacillus subtilis 3020, 
Streptomyces rimosus R7, and mold Aspergillus ni-
ger 405. All microorganisms are stored on agar 
slopes in the refrigerator at +4 °C at the Faculty of 
Chemical Engineering and Technology, Zagreb. For 
the cultivation of the mentioned microorganisms, 
nutrient agar (Biolife, Italy) and malt extract agar 
(Biolife, Italy) were prepared. The microorganisms 
were cultivated by inoculating the nutrient agar 
plates with Pseudomonas aeruginosa 3011 and Ba-
cillus subtilis 3020, and incubated at 37 °C for 24 
hours, while Streptomyces rimosus R7 and Asper-
gillus niger 405 were cultivated on malt extract 
agar plates and incubated at 28 °C for 3 days. The 
antimicrobial susceptibility tests were conducted 
with the selected environmental microorganisms. 
The concentration of erythromycin in the antimicro-
bial susceptibility tests ranged from 0.02 to 2000 
mg dm–3. The inoculated agar plates with discs on 
surface were incubated in the same conditions as 
previously indicated for each microorganism.
Biodegradation experiments
Three experiments, Exp. 1, Exp. 2 and Exp. 3, 
were conducted. In Exp. 1, the biodegradation of 
erythromycin by B. subtilis 3020 was studied. The 
other two experiments studied the biodegradation of 
erythromycin by P. aeruginosa 3011. Suspensions 
of bacterial cultures P. aeruginosa 3011 and B. sub-
tilis 3020 were prepared, and their optical density 
was determined spectrophotometrically at λ = 600 
nm of 0.7 and 1.5, respectively (Hach, model 
DR/2400, USA). The colony-forming unit was de-
termined at the beginning of the experiment using 
the decimal dilutions method. The colony-forming 
units of B. subtilis 3020 were 2.2· 107 CFU cm–3 in 
Exp. 1, while for the P. aeruginosa 3011 they were 
8.6· 108 CFU cm–3 in Exp. 2, and 5.5· 108 in Exp. 3.
The substrate used in the biodegradation exper-
iments was a macrolide antibiotic, erythromycin 
(PLIVA Hrvatska d.o.o.). Erythromycin was dis-
solved in water at the temperature of 28 °C20. Work-
ing solutions were prepared in the following con-
centrations: γ01 = 0.02 mg dm
–3, γ02 = 0.2 mg dm
–3, 
γ03 = 2 mg dm
–3, γ04 = 20 mg dm
–3, γ05 = 50 mg 
dm–3, γ06 = 80 mg dm
–3, γ07 = 100 mg dm
–3, γ08 = 150 
mg dm–3, γ09 = 200 mg dm
–3, γ10 = 2000 mg dm
–3. 
The initial erythromycin concentrations are marked 
as S1-S10. Concentration of erythromycin before 
and after the experiments was monitored by ultra 
performance liquid chromatography (Waters 
H-Class, USA), at λ = 210 nm, using column Wa-
ters BEH C-18 100×21 mm. The mobile phase, 
pumped at 0.61 cm3 min–1, consisted of 12.7 mmol 
dm–3 anhydrous disodium hydrogen phosphate dis-
solved in water, pH 8.9 (A) and 25 % methanol in 
acetonitrile (B) with gradient elution. The initial 
conditions of biodegradation in Exp. 1 – Exp. 3 
with an initial number of colony-forming units, 
CFU, and the initial concentration of the substrate 
S1-S10 are shown in Table 1. In the first two exper-
iments, concentrations of erythromycin were used 
according to the logarithmic scale, from the lowest 
S01 = 0.02 mg dm
–3, up to the largest, S10 = 2000 mg 
dm–3. In Exp. 3, the concentration interval was re-
duced from S04 = 20 mg dm
–3 to S09 = 200 mg dm
–3.
Biodegradation experiments were conducted in 
Erlenmeyer flasks (100 cm3) in an incubator shaker 




(cells cm–3) S1 S2 S3 S4 S5 S6 S7 S8 S9 S10
1 4.3· 107 + + + + – – – – + +
2   1.1· 1010 + + + + – – – – + +
3 4.3· 108 – – – + + + + + + –
“+“ – analyzed concentrations
”–“ – not analyzed concentrations
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(Unimax 1010, Heidolph) at 28 °C and 160 rpm for 
64 hours in Exp. 1, and 24 hours in Exp. 2 and Exp. 
3. To remove the possibility of photodegradation of 
erythromycin, the experiments were performed in 
the dark.21
Erlenmeyer flasks contained 1 cm3 of the sus-
pension of microorganisms, 4 cm3 of phosphate buf-
fer (0.85 g KH2PO4, 2.18 g K2HPO4 and 3.34 g 
Na2HPO4· 7H2O in 100 cm
3 distilled water, pH = 
7.36), 21 cm3 of BOD dilution water, 10 cm3 of nu-
trient solution (0.8 g nutrient broth and 0.6 g sodi-
um acetate dissolved in 100 cm3 distilled water)22, 
and 4 cm3 of the prepared test solutions of erythro-
mycin with initial concentrations S1-S10. BOD di-
lution water was prepared by adding 1 cm3 of each 
of the following solutions to 1 dm3 distilled water: 
magnesium sulfate solution (2.3 g MgSO4· 7H2O in 
100 cm3 distilled water), calcium chloride solution 
(2.8 g CaCl2 in 100 cm
3 distilled water), ferric chlo-
ride solution (25 mg FeCl3· 6H2O in 100 cm
3 dis-
tilled water) and ammonium chloride solution (170 
mg NH4Cl in 100 cm
3 distilled water). The control 
solution was prepared with 25 cm3 of BOD dilution 
water without the test solution of erythromycin, and 
it was used to correct for sample turbidity, color or 
precipitation in test solutions.22 All test concentra-
tions were prepared in duplicate.
The pH-value of solutions that were used in the 
biodegradation experiment and the final mixture 
solution were tested prior to implementation in all 
experiments. The pH ranged from 6.5 to 7.3, and 
the final pH of the mixture solution was about 7.5. 
The pH value is very important for conducting this 
experiment because erythromycin23 is inactive at pH 
values lower than 3, while the optimal pH value for 
the growth of microorganisms is 6–9.24
During the experiments, the samples were mon-
itored for changes in optical density. Samples were 
Gram stained after 16 and 24 hours, and microscopic 
analysis was conducted under light microscope 
(Olympus BX50, Olympus Optical Co Ltd., Japan) 
equipped with a microphotography system (Olympus 
DP 10 camera). Samples were filtered and dried at 
the end of the experiments to determine the concen-
tration of biomass and residual concentrations of 
erythromycin. In addition, the colony-forming unit 
was determined at the end of the experiment.
Results and discussion
Antimicrobial susceptibility testing
Before setting up the biodegradation experi-
ment, antimicrobial susceptibility tests were con-
ducted with selected environmental microorgan-
isms. The results of the preformed experiments are 
shown in Table 2.
The results show that the most susceptible mi-
croorganism to erythromycin was Bacillus subtilis 
3020. This is because erythromycin is effective 
against Gram-positive bacteria.25 The bacteria Strep-
tomyces rimosus R7 had intermediate resistance to 
the tested antibiotic, even though it is a Gram-posi-
tive bacteria as B. subtilis 3020. This is because it 
belongs to the genus of Streptomyces, which have 
the ability of producing antibiotics and probably have 
resistance genes for the same one.26 The bacteria 
Pseudomonas aeruginosa 3011 and mold Aspergillus 
niger 405 were resistant to a wide range of examined 
concentrations of erythromycin. Enzyme erythromy-
cin esterase was successfully isolated from Pseudo-
monas sp., which increased the resistance of the said 
microorganism on the tested pharmaceutical.27 It is 
possible that the bacteria Pseudomonas aeruginosa 
3011 has the same enzyme because it belongs to the 
same genus of bacteria, and therefore does not show 
susceptibility to erythromycin.
Biodegradation process
The results from Exp.1 shown in Fig. 1, indi-
cate that the lower concentration of substrate is less 
toxic, respectively, the sample is similar to the con-
trol. This means that the bacterial culture had grown 
at lower concentrations of erythromycin. The toxic 
concentration which prevented growth of B. subtilis 
3020 in the first 24 hours was 2 mg dm–3. For the 
concentration of erythromycin of 0.02 mg dm–3 the 
sample was 90.17 % similar to the control, while 
for the concentration of erythromycin of 0.2 mg 
dm–3 the absorbance of the sample was greater than 
for the control solution. Therefore, it can be con-
cluded that there was no inhibition in the assay, re-
spectively, bacteria B. subtilis 3020 showed resis-
tance to concentrations of erythromycin lower than 
2 mg dm–3. In addition, from Fig. 1 it is evident 













0.02 / no zone / no zone
0.2 / no zone / no zone
2 / 8 ; – ; – / no zone
20 / 10 ; 17 ; – / /
50 9 ; – ; – 14 ; 20 ; 27 no zone no zone
100 10 ; – ; – 17 ; 22 ; 30 no zone no zone
200 12 ; 15 ; – 19 ; 23 ; 31 no zone no zone
2000 / 21 ; 27 ; – / 12 ; 20 ; –
/ – test was not conducted
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that, in the 36th hour, absorbance of the sample 
with a concentration of erythromycin of 2 mg dm–3 
began to grow, and that in the 64th hour the sample 
was 72.92 % similar to the control. This indicates 
the adjustment of the bacterial culture B. subtilis 
3020 on substrate, erythromycin. In this experiment, 
erythromycin showed inhibitory activity and not 
bactericidal.28 The results also showed that there 
was a drop percentage of control in the 36th and 
64th hour of the sample with the concentration of 
the substrate of 0.2 mg dm–3. Absorbance values 
dropped 1.7 times in the 36th hour, and 1.6 times in 
the 64th hour. This means that there was a decay of 
biomass because of the disappearance of nutrients 
or due to the toxic influence of the substrate. Based 
on the results, the biodegradation time in further ex-
periments was defined as 24 hours.
In Exp. 2, after 16 hours, the production of bio-
mass started in the experimental solutions in a form 
of brown fibers. Production of biomass was ex-
pressed in control samples and in samples with a 
lower concentration of substrate (0.02–20 mg dm–3), 
whereas in the samples with a substrate concentra-
tion of 200 and 2000 mg dm–3, biomass accumulation 
occurred only around the 24th hour. This was proba-
bly caused by the high concentration of substrate, i.e. 
it was necessary for the biomass to adjust to the con-
ditions in the reactor so that it could have begun to 
grow rapidly. Also, in the course of this experiment, 
the green-yellow pigment pyocyanin appeared in the 
control samples after 24 hours, which is characteris-
tic for the bacteria P. aeruginosa. In the other sam-
ples, the pigment did not appear as a result of the 
presence of a substrate, which probably acted as an 
inhibitor to the production of the pigment.29
The results shown in Fig. 2 indicate that the 
samples with lower concentration are more similar to 
control solutions. In this experiment, all tested con-
centrations of erythromycin showed no inhibitory ac-
tivity, except S10, 2000 mg dm–3, where there was a 
complete inhibition of growth of bacterial culture. 
The sample was consistent with control of 22.0 % 
after 24 hours, while for other concentration samples 
this value was 90–100 %, which is 4.5 times higher 
absorbance. The results show that in the 16th hour, 
production of biomass reached a maximum, and then 
at 20th and 24th hour, the values slightly declined. 
The exception was the sample with the concentration 
of substrate S10, 2000 mg dm–3 where the rise in the 
percentage of control over time was present from 8.6 
% to 22.0 %, indicating the adaptation of bacterial 
culture to adverse effects.30
In Exp. 2, the resistance of the tested microor-
ganism was observed according to almost all tested 
concentrations of substrate. IC50, 50 % inhibition 
concentration, is a concentration of substance, 
which inhibits the growth of bacterial cells by 50 
%.22 According to the results above, IC50 value for 
erythromycin was 124.2 mg dm–3.
The Exp. 3 was conducted for interval of concen-
trations from S4 to S9. The results of Exp. 3 are shown 
in Fig. 3. It can be seen that none of the tested concen-
trations of erythromycin had an inhibitory effect on 
the bacterial culture P. aeruginosa 3011. The results 
show that the values in the 16th hour were more than 
F i g .  1  – Change in the percentage of the controls and the 
concentration of substrates S1–S4, S9 and S10 in the process of 
biodegradation of erythromycin with B. subtilis 3020 in Exp. 1
F i g .  2  – Change in the percentage of the controls and the con-
centration of substrates S1–S4, S9 and S10 in the process of bio-
degradation of erythromycin with P. aeruginosa 3011 in Exp. 2
F i g .  3  – Change in the percentage of the controls and the 
concentration of substrates S4–S9 in the process of biodegra-
dation of erythromycin with P. aeruginosa 3011 in Exp. 3
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100 % for the lower concentrations, and after 24 hours 
the values decreased. This indicates the possibility of 
biodegradation, as the bacteria, after adjusting to the 
present conditions and after utilization of simple nutri-
ent sources, started to degrade the complex organic 
molecules, in this case erythromycin.30,31 After the bac-
teria had utilized all the nutrients, the biomass began 
to decrease, which is evident after 24 hours. In addi-
tion, it is shown that the biomass concentration in-
creased in all samples, regardless of the concentration 
of substrate, which suggests possible adaptation of the 
bacterial culture to the conditions in the reactor.
The effectiveness of the biodegradation process 
was observed by determination of the concentra-
tion of erythromycin at the beginning and end of 
Exp. 3. From the results shown in Fig. 4, it is  evident 
that the percentages of biodegradation for all tested 
concentrations of substrate in the solutions were 
similar. This indicates that the selection of the bacte-
rial culture Pseudomonas aeruginosa 3011 for the 
experiment of possible erythromycin biodegradation, 
was good because in only 24 hours, the pure bacteri-
al culture was able to biodegrade 33.43±5.7 % of the 
complex organic molecule.12
Microbiological analysis
To find out how many viable bacterial cells were 
present in a sample, the colony-forming units were de-
termined.24 The results for Exp. 1 – Exp. 3 are shown in 
Table 3. From the results, it can be seen that the average 
number of viable  bacterial cells of Bacillus subtilis 
3020 for the  tested concentrations of erythromycin was 
8.9· 106 CFU cm–3. The number of viable Pseudomonas 
aeru ginosa 3011 cells in Exp. 2 decreased to 7.1· 107 
CFU cm–3, while in Exp. 3 the number of viable bacte-
ria cells maintained in all tested erythro mycin concen-
trations. The results indicate that Gram-positive bacte-
ria are more susceptible to erythromycin.25
Although the results shown in Figs. 1–3 indi-
cate that biomass concentration during biodegrada-
tion did not differ from the control solutions, differ-
ences in the number of living cells are visible even 
at the lowest concentrations of erythromycin. Thus, 
at concentrations of substrate S1, 0.02 mg dm–3 in 
Exp. 1 and Exp. 2, 10 times less bacteria had sur-
vived than in the control solution. These results 
show that there was a specific inhibition of cell 
growth present in the experiments, probably at the 
beginning when the bacterial cultures had not yet 
adapted to the new conditions.32
Microorganisms use organic substances as a 
source of nutrients and energy.24 Microscopic analysis 
consisted of a visual examination and determination of 
the morphological characteristics of the cells. Micro-
photographs of bacterial culture Bacillus subtilis 3020 
used in Exp. 1, and stained according to Gram, are 
shown in Fig. 5. It can be seen that, with increasing 
the initial concentration of erythromycin in the experi-
ments, bacterial cells morphologically changed, re-
spectively, the bacterial cells became elongated and 
the chains of bacteria broke. Erythromycin binds to 
50S subunit of ribosomal RNA and in that way causes 
inhibition of the synthesis of proteins.33 It is possible 
that erythromycin causes damage to the cytoplasmic 
membrane and compromises cell wall synthesis, lead-
ing to loss of cytoplasmic material34, which can result 
in change of cell structure.
A microphotograph of control solutions with 
bacterial culture Pseudomonas aeruginosa 3011 is 
given in Fig. 6a. It is evident that the cells are small 
and that it is a Gram-negative bacterium.12 The chang-
es in the size of bacterial cells occurred with the in-
crease in concentrations of the substrate. The sample 
with the lowest concentration of S1, 0.02 mg dm–3 
was smaller and fitted the pattern of the control solu-
tion. The higher the concentration of erythromycin in 
the sample, the larger were the bacterial cells. We as-
F i g .  4  – Efficiency of biodegradation process of erythromy-
cin in Exp. 3
Ta b l e  3  – Values of the total number of viable cells for differ-




Exp. 1 Exp. 2 Exp. 3
0 (control) 4.3· 107 1.1· 1010 4.3· 108
0.02 3.5· 106 2.8· 109 /
0.2 4.4· 106 / /
2 5.4· 105 / /
20 1.8· 105 5.2· 109 3.2· 108
100 / / 2.7· 108
150 / / 2.4· 108
200 / 4.2· 109 2.8· 108
2000 3.1· 105 7.1· 107 /
/ – analysis was not conducted
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sume that this may be due to the adjustment of the 
bacterial culture P. aeruginosa 3011 to the new con-
ditions, where the nutrient is a hardly degradable 
substance. The morphology of living cells varied 
with the concentration of the substrate, i.e. the higher 
the concentration of erythromycin, the larger the cells 
were, but the value of CFU of the bacterial culture P. 
aeruginosa 3011 was lower.
Conclusion
In order to prevent potential problems in the 
ecosystems, pharmaceuticals have to be removed in 
an economically effective but eco-friendly way, such 
as biodegradation. Removal efficiency can be im-
proved by inoculating naturally occurring microor-
ganisms into contaminated sites. The obtained results 
have shown biodegradation efficiency of erythromy-
cin by different environmental microorganisms. 
During antimicrobial susceptibility tests and biodeg-
radation experiments, Pseudomonas aeruginosa 3011 
showed high resistance to various concentrations of 
erythromycin. The average biodegradation of eryth-
romycin for Exp. 3 was 33.43 % after 24 hours. The 
highest removal efficiency of erythromycin obtained 
was 44.1 % for the substrate concentration S4. The 
concentration of erythromycin affects the morpholo-
gy of P. aeruginosa 3011, i.e. by increasing the con-
centration of erythromycin, the concentration of bio-
mass reduced and the cells grew bigger. 
Biodegradation of erythromycin by bacteria P. aeru-
ginosa 3011 shows good results, and can serve as a 
basis for further research in the area of biological 
treatment of waste streams.
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